1. Home
  2. FGEN vs KPLT Comparison

FGEN vs KPLT Comparison

Compare FGEN & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • KPLT
  • Stock Information
  • Founded
  • FGEN 1993
  • KPLT 2012
  • Country
  • FGEN United States
  • KPLT United States
  • Employees
  • FGEN N/A
  • KPLT N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • KPLT Diversified Commercial Services
  • Sector
  • FGEN Health Care
  • KPLT Consumer Discretionary
  • Exchange
  • FGEN Nasdaq
  • KPLT Nasdaq
  • Market Cap
  • FGEN 33.5M
  • KPLT 35.6M
  • IPO Year
  • FGEN 2014
  • KPLT N/A
  • Fundamental
  • Price
  • FGEN $5.61
  • KPLT N/A
  • Analyst Decision
  • FGEN Strong Buy
  • KPLT Hold
  • Analyst Count
  • FGEN 1
  • KPLT 2
  • Target Price
  • FGEN $250.00
  • KPLT $12.00
  • AVG Volume (30 Days)
  • FGEN 60.2K
  • KPLT 26.3K
  • Earning Date
  • FGEN 08-05-2025
  • KPLT 08-13-2025
  • Dividend Yield
  • FGEN N/A
  • KPLT N/A
  • EPS Growth
  • FGEN N/A
  • KPLT N/A
  • EPS
  • FGEN N/A
  • KPLT N/A
  • Revenue
  • FGEN $6,996,000.00
  • KPLT $254,079,000.00
  • Revenue This Year
  • FGEN N/A
  • KPLT $22.26
  • Revenue Next Year
  • FGEN N/A
  • KPLT $11.03
  • P/E Ratio
  • FGEN N/A
  • KPLT N/A
  • Revenue Growth
  • FGEN N/A
  • KPLT 9.72
  • 52 Week Low
  • FGEN $4.50
  • KPLT $5.08
  • 52 Week High
  • FGEN $38.25
  • KPLT $21.88
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 39.07
  • KPLT 44.48
  • Support Level
  • FGEN $4.85
  • KPLT $7.37
  • Resistance Level
  • FGEN $5.77
  • KPLT $8.44
  • Average True Range (ATR)
  • FGEN 0.57
  • KPLT 0.77
  • MACD
  • FGEN -0.02
  • KPLT -0.06
  • Stochastic Oscillator
  • FGEN 31.67
  • KPLT 21.86

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.

About KPLT Katapult Holdings Inc.

Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.

Share on Social Networks: